AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity
A discussion on a recent randomized clinical trial published in the New England Journal that examined the effects of semaglutide versus placebo in heart failure patients with obesity. The trial showed positive results, with the semaglutide group experiencing greater symptom improvement, physical limitation, and weight loss.